Amylin Pharmaceuticals, Inc. competitive analysis

Loading summary...

Explore Amylin Pharmaceuticals, Inc.'s recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 6, 2025
Patent NumberGrant DateTitleTotal Oppositions
Sep 13, 2023Sustained Release Formulations Using Non-Aqueous Carriers1
May 8, 2019Exendin For Treating Diabetes And Reducing Body Weight2

Latest PTAB cases involving Amylin Pharmaceuticals, Inc.

Discover the latest PTAB cases involving Amylin Pharmaceuticals, Inc., highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Amylin Pharmaceuticals, Inc. with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 6, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
AMYLIN PHARMACEUTICALS - 3 - 4
GENERICS UK214 - - -
INSTONE7 - - -